Status:
UNKNOWN
Lidocaine Infusion for Propofol Dose Reduction in ERCP Procedure
Lead Sponsor:
Iuliu Hatieganu University of Medicine and Pharmacy
Conditions:
Sedation
Eligibility:
All Genders
65-85 years
Phase:
PHASE1
Brief Summary
This study aims to investigate the dose reduction of propofol if associated with continuous infusion of lidocaine during ERCP procedures in patients over 65 years old.
Detailed Description
The primary aim of this study was to evaluate the effect of continuous infusion of lidocaine on propofol consumption in older patients having ERCP sedation. Secondary outcomes were to evaluate patient...
Eligibility Criteria
Inclusion
- 65-85 years old
- physical status ASA I, II, III,
- ERCP scheduled
Exclusion
- ASA IV or higher
- severe renal, cardiac or liver failure,
- allergy to lidocaine,
- patients weighing less than 40 kg,
- inability to give informed consent
Key Trial Info
Start Date :
January 3 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 3 2022
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT05274984
Start Date
January 3 2022
End Date
April 3 2022
Last Update
March 11 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Regional Institute of Gastroenterology and Hepatology "Prof.dr.Octavian Fodor"
Cluj-Napoca, Cluj, Romania, 400162